Appili Therapeutics, Inc. (APLIF)
0.0055
0.00 (0.00%)
USD |
OTCM |
Oct 16, 16:00
Appili Therapeutics Total Assets (Quarterly) : 0.9129M for June 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.9129M |
| March 31, 2026 | 1.414M |
| December 31, 2025 | 0.3997M |
| September 30, 2025 | 0.5422M |
| June 30, 2025 | 1.393M |
| March 31, 2025 | 2.107M |
| December 31, 2024 | 1.456M |
| September 30, 2024 | 1.150M |
| June 30, 2024 | 1.632M |
| March 31, 2024 | 1.101M |
| December 31, 2023 | 1.493M |
| September 30, 2023 | 1.448M |
| June 30, 2023 | 1.640M |
| March 31, 2023 | 2.314M |
| December 31, 2022 | 1.91M |
| September 30, 2022 | 2.843M |
| June 30, 2022 | 5.532M |
| Date | Value |
|---|---|
| March 31, 2022 | 6.630M |
| December 31, 2021 | 8.995M |
| September 30, 2021 | 9.388M |
| June 30, 2021 | 9.613M |
| March 31, 2021 | 14.57M |
| December 31, 2020 | 16.90M |
| September 30, 2020 | 17.76M |
| June 30, 2020 | 19.25M |
| March 31, 2020 | 7.850M |
| December 31, 2019 | 2.359M |
| September 30, 2019 | 2.861M |
| June 30, 2019 | 3.946M |
| March 31, 2019 | 5.116M |
| December 31, 2018 | 4.438M |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | 5.578M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| InMed Pharmaceuticals, Inc. | 3.030M |
| NervGen Pharma Corp. | 63.57M |
| Milestone Pharmaceuticals, Inc. | 181.62M |
| Clearmind Medicine, Inc. | 16.91M |
| Lexaria Bioscience Corp. | 4.781M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 14.32M |
| Shareholders Equity (Quarterly) | -13.41M |
| Debt to Equity Ratio | -0.7005 |
| Current Ratio | 0.0653 |
| Net Debt Paydown Yield | -11.67% |